|
| |
Incenta LimitedIncenta is a young, Cambridge UK "chemitech" company operating within the biotech sector. The company enshrines a structure-based drug design business focused on the generation and exemplification of proprietary, potent and selective compounds that improve human health.
Incenta was launched in November 2000 by Bill Turnell and Alan Goodman, together with founding scientists Dr Manoj Ramjee and Dr Martin Quibell.The company was established to exploit the distinctive but complementary skills of Bill, Manoj and Martin in the use of structure activity relationships of natural ligands to design, synthesise and test novel drugs and candidate vaccines.
| Contact Details: |
| Horizon Park, Barton Road |
| Comberton |
| Cambridgeshire |
| CB3 7AJ |
| United Kingdom |
| Tel: | +44 (0) 1223 264 211 |
| Fax: | +44 (0) 1223 265 662 |
| Email: | reception@incenta.co.uk |
| WWW: | www.incenta.com/
|
| |
Recent Publications by Incenta Limited: |  |
Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases.
A stereoselective synthesis of functionalised... | 16th August, 2005
| Amura Therapeutics Limited, Incenta House, Horizon Park, Barton Road,
| Bioorg Med Chem. 2005 Feb 1;13(3):609-25.
DOI Direct Link |
cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene and cis-6-oxo-hexahydropyrrolo[3,2-c]pyrazole based scaffolds: design rationale, synthesis and cysteinyl proteinase inhibition.
The 5,5-bicycles cis-6-oxo-hexahydro-2-oxa-1,4-diazapentalene 3 and... | 6th July, 2005
| Amura Therapeutics Limited, Incenta House, Horizon Park, Barton Road,
| Bioorg Med Chem Lett. 2005 Mar 1;15(5):1327-31.
DOI Direct Link |
Bicyclic peptidomimetic tetrahydrofuro[3,2-b]pyrrol-3-one and hexahydrofuro[3,2-b]pyridine-3-one based scaffolds: synthesis and cysteinyl proteinase inhibition.
A stereoselective synthesis of... | 19th March, 2005
| Amura Therapeutics Limited, Incenta House, Horizon Park, Barton Road,
| Bioorg Med Chem. 2004 Nov 1;12(21):5689-710.
DOI Direct Link |
Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibition.
A stereoselective synthesis of functionalised... | 15th January, 2005
| Amura Therapeutics Limited, Incenta House, Horizon Park, Barton Road,
| Bioorg Med Chem. 2004 Jun 1;12(11):2903-25.
DOI Direct Link |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 458 times since April 2007, the link to the organisation's website has been followed 137 times Recent Search Terms used to find this page: www.incenta.com | www.incenta.com | bill turnell | bill turnell | bill turnell | incenta turnell | incenta ltd | bill turnell | incenta | incenta.com | . Search for more companies in Comberton Search for more companies in Cambridgeshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Incenta Limited |
